BackForesee Pharmaceuticals , Ltd. Overview

Foresee Pharmaceuticals , Ltd. Accounts Payable

Foresee Pharmaceuticals , Ltd.'s accounts payable is $20M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$20.11M
↓ 60.71% YoYΔ $-31.08M vs prior year quarter

Peer trimmed avg / median

Loading

Foresee Pharmaceuticals , Ltd. Accounts Payable History

Loading

Foresee Pharmaceuticals , Ltd. vs. peers: Accounts Payable Comparison

Loading

Foresee Pharmaceuticals , Ltd. Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Foresee Pharmaceuticals , Ltd. (6576.TWO) FAQ

As of the most recent data (June 2026), 6576.TWO shows a accounts payable of $20M. That compares with $51M in the prior-year period — down 60.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6576.TWO's accounts payable is now $20M (was $51M) — a 60.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Foresee Pharmaceuticals , Ltd. is outperforming or lagging.

Tracking 6576.TWO's accounts payable over time shows whether Foresee Pharmaceuticals , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $51M in the prior-year period — down 60.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Foresee Pharmaceuticals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $20M) with ownership activity and broader fundamentals.